These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 11673750

  • 1. Effect of rifampin and tobacco smoking on the pharmacokinetics of ropivacaine.
    Jokinen MJ, Olkkola KT, Ahonen J, Neuvonen PJ.
    Clin Pharmacol Ther; 2001 Oct; 70(4):344-50. PubMed ID: 11673750
    [Abstract] [Full Text] [Related]

  • 2. Metabolism and excretion of ropivacaine in humans.
    Halldin MM, Bredberg E, Angelin B, Arvidsson T, Askemark Y, Elofsson S, Widman M.
    Drug Metab Dispos; 1996 Sep; 24(9):962-8. PubMed ID: 8886605
    [Abstract] [Full Text] [Related]

  • 3. Effect of ciprofloxacin on the pharmacokinetics of ropivacaine.
    Jokinen MJ, Olkkola KT, Ahonen J, Neuvonen PJ.
    Eur J Clin Pharmacol; 2003 Feb; 58(10):653-7. PubMed ID: 12610740
    [Abstract] [Full Text] [Related]

  • 4. Effect of rifampin on the pharmacokinetics and pharmacodynamics of gliclazide.
    Park JY, Kim KA, Park PW, Park CW, Shin JG.
    Clin Pharmacol Ther; 2003 Oct; 74(4):334-40. PubMed ID: 14534520
    [Abstract] [Full Text] [Related]

  • 5. Rifampin greatly reduces plasma simvastatin and simvastatin acid concentrations.
    Kyrklund C, Backman JT, Kivistö KT, Neuvonen M, Laitila J, Neuvonen PJ.
    Clin Pharmacol Ther; 2000 Dec; 68(6):592-7. PubMed ID: 11180018
    [Abstract] [Full Text] [Related]

  • 6. The effect of rifampin on the pharmacokinetics of oral and intravenous ondansetron.
    Villikka K, Kivistö KT, Neuvonen PJ.
    Clin Pharmacol Ther; 1999 Apr; 65(4):377-81. PubMed ID: 10223773
    [Abstract] [Full Text] [Related]

  • 7. Metabolism of ropivacaine in humans is mediated by CYP1A2 and to a minor extent by CYP3A4: an interaction study with fluvoxamine and ketoconazole as in vivo inhibitors.
    Arlander E, Ekström G, Alm C, Carrillo JA, Bielenstein M, Böttiger Y, Bertilsson L, Gustafsson LL.
    Clin Pharmacol Ther; 1998 Nov; 64(5):484-91. PubMed ID: 9834040
    [Abstract] [Full Text] [Related]

  • 8. Effect of rifampicin on the pharmacokinetics of imatinib mesylate (Gleevec, STI571) in healthy subjects.
    Bolton AE, Peng B, Hubert M, Krebs-Brown A, Capdeville R, Keller U, Seiberling M.
    Cancer Chemother Pharmacol; 2004 Feb; 53(2):102-6. PubMed ID: 14605865
    [Abstract] [Full Text] [Related]

  • 9. Effects of trimethoprim and rifampin on the pharmacokinetics of the cytochrome P450 2C8 substrate rosiglitazone.
    Niemi M, Backman JT, Neuvonen PJ.
    Clin Pharmacol Ther; 2004 Sep; 76(3):239-49. PubMed ID: 15371985
    [Abstract] [Full Text] [Related]

  • 10. Rifampin markedly decreases and gemfibrozil increases the plasma concentrations of atorvastatin and its metabolites.
    Backman JT, Luurila H, Neuvonen M, Neuvonen PJ.
    Clin Pharmacol Ther; 2005 Aug; 78(2):154-67. PubMed ID: 16084850
    [Abstract] [Full Text] [Related]

  • 11. The pharmacokinetics of ropivacaine after intraperitoneal administration: instillation versus nebulization.
    Betton D, Greib N, Schlotterbeck H, Joshi GP, Ubeaud-Sequier G, Diemunsch P.
    Anesth Analg; 2010 Nov; 111(5):1140-5. PubMed ID: 20841409
    [Abstract] [Full Text] [Related]

  • 12. Effect of clarithromycin and itraconazole on the pharmacokinetics of ropivacaine.
    Jokinen MJ, Ahonen J, Neuvonen PJ, Olkkola KT.
    Pharmacol Toxicol; 2001 Apr; 88(4):187-91. PubMed ID: 11322176
    [Abstract] [Full Text] [Related]

  • 13. Effects of gemfibrozil, itraconazole, and their combination on the pharmacokinetics of pioglitazone.
    Jaakkola T, Backman JT, Neuvonen M, Neuvonen PJ.
    Clin Pharmacol Ther; 2005 May; 77(5):404-14. PubMed ID: 15900286
    [Abstract] [Full Text] [Related]

  • 14. Enzyme induction in the elderly: effect of rifampin on the pharmacokinetics and pharmacodynamics of propafenone.
    Dilger K, Hofmann U, Klotz U.
    Clin Pharmacol Ther; 2000 May; 67(5):512-20. PubMed ID: 10824630
    [Abstract] [Full Text] [Related]

  • 15. Pharmacokinetics of ropivacaine in patients with chronic renal failure.
    Pere PJ, Ekstrand A, Salonen M, Honkanen E, Sjövall J, Henriksson J, Rosenberg PH.
    Br J Anaesth; 2011 Apr; 106(4):512-21. PubMed ID: 21307007
    [Abstract] [Full Text] [Related]

  • 16. Rifampin reduces plasma concentrations and effects of zolpidem.
    Villikka K, Kivistö KT, Luurila H, Neuvonen PJ.
    Clin Pharmacol Ther; 1997 Dec; 62(6):629-34. PubMed ID: 9433391
    [Abstract] [Full Text] [Related]

  • 17. Smoking accelerates absorption of inhaled neutrophil elastase inhibitor FK706.
    Koizumi F, Murakami M, Kageyama H, Katashima M, Terakawa M, Ohnishi A.
    Clin Pharmacol Ther; 1999 Nov; 66(5):501-8. PubMed ID: 10579477
    [Abstract] [Full Text] [Related]

  • 18. Effect of rifampin on the pharmacokinetics of rosiglitazone in healthy subjects.
    Park JY, Kim KA, Kang MH, Kim SL, Shin JG.
    Clin Pharmacol Ther; 2004 Mar; 75(3):157-62. PubMed ID: 15001966
    [Abstract] [Full Text] [Related]

  • 19. Aging and drug interactions. II. Effect of phenytoin and smoking on the oxidation of theophylline and cortisol in healthy men.
    Crowley JJ, Cusack BJ, Jue SG, Koup JR, Park BK, Vestal RE.
    J Pharmacol Exp Ther; 1988 May; 245(2):513-23. PubMed ID: 3367304
    [Abstract] [Full Text] [Related]

  • 20. Smoking behaviour modulates pharmacokinetics of orally administered clopidogrel.
    Yousef AM, Arafat T, Bulatova NR, Al-Zumyli R.
    J Clin Pharm Ther; 2008 Aug; 33(4):439-49. PubMed ID: 18613862
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.